Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis ; volume:14 ; number:1 ; day:29 ; month:2 ; year:2016 ; pages:1-5 ; date:12.2016
Pediatric rheumatology ; 14, Heft 1 (29.2.2016), 1-5, 12.2016
- Creator
-
Scheuern, Andrea
- Contributor
-
Fischer, Nadine
McDonald, Joseph
Brunner, Hermine I.
Haas, Johannes-Peter
Hügle, Boris
SpringerLink (Online service)
- DOI
-
10.1186/s12969-016-0071-y
- URN
-
urn:nbn:de:1111-2016030230058
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Scheuern, Andrea
- Fischer, Nadine
- McDonald, Joseph
- Brunner, Hermine I.
- Haas, Johannes-Peter
- Hügle, Boris
- SpringerLink (Online service)
Other Objects (12)
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Methotrexate intolerance in Rheumatoid Arthritis
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS)
Intolerance in oral versus subcutaneous administration of methotrexate in patients with juvenile idiopathic arthritis: a cross-sectional, observational study
Validation of Methotrexate Intolerance Severity Score (MISS) questionnaire to measure methotrexate intolerance among rheumatoid arthritis Egyptian patients
MTHFR polymorphism and red cell folate levels are not useful as biomarkers of methotrexate efficacy and toxicity in children with juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Does caffeine reduce methotrexate intolerance in patients with rheumatoid arthritis: a randomized controlled study
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Methotrexate intolerance in Rheumatoid Arthritis
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS)
Intolerance in oral versus subcutaneous administration of methotrexate in patients with juvenile idiopathic arthritis: a cross-sectional, observational study
Validation of Methotrexate Intolerance Severity Score (MISS) questionnaire to measure methotrexate intolerance among rheumatoid arthritis Egyptian patients
MTHFR polymorphism and red cell folate levels are not useful as biomarkers of methotrexate efficacy and toxicity in children with juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Does caffeine reduce methotrexate intolerance in patients with rheumatoid arthritis: a randomized controlled study
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Methotrexate intolerance in Rheumatoid Arthritis
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS)
Intolerance in oral versus subcutaneous administration of methotrexate in patients with juvenile idiopathic arthritis: a cross-sectional, observational study
Validation of Methotrexate Intolerance Severity Score (MISS) questionnaire to measure methotrexate intolerance among rheumatoid arthritis Egyptian patients
MTHFR polymorphism and red cell folate levels are not useful as biomarkers of methotrexate efficacy and toxicity in children with juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Does caffeine reduce methotrexate intolerance in patients with rheumatoid arthritis: a randomized controlled study
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis